These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9671405)

  • 21. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML.
    Ahn JH; Brignole EJ; Hayward GS
    Mol Cell Biol; 1998 Aug; 18(8):4899-913. PubMed ID: 9671498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
    Subramanian D; Bunjobpol W; Sabapathy K
    J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
    Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
    Qiu JJ; Chu H; Lu X; Jiang X; Dong S
    Oncogene; 2011 Feb; 30(8):967-77. PubMed ID: 20972455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
    Kim S; Denny CT; Wisdom R
    Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of three major sentrinization sites in PML.
    Kamitani T; Kito K; Nguyen HP; Wada H; Fukuda-Kamitani T; Yeh ET
    J Biol Chem; 1998 Oct; 273(41):26675-82. PubMed ID: 9756909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalpha.
    Yang WL; Zeng YX; El-Deiry WS; Nason-Burchenal K; Dmitrovsky E; Chin KV
    Mol Cell Biol Res Commun; 1999 May; 1(2):125-31. PubMed ID: 10356361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional synergy mediated by SAF-1 and AP-1: critical role of N-terminal polyalanine and two zinc finger domains of SAF-1.
    Kumar D; Ray A; Ray BK
    J Biol Chem; 2009 Jan; 284(3):1853-62. PubMed ID: 19028685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.
    Khan MM; Nomura T; Kim H; Kaul SC; Wadhwa R; Shinagawa T; Ichikawa-Iwata E; Zhong S; Pandolfi PP; Ishii S
    Mol Cell; 2001 Jun; 7(6):1233-43. PubMed ID: 11430826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
    Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
    Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of promyelocytic leukemia (PML) protein in tumor suppression.
    Rego EM; Wang ZG; Peruzzi D; He LZ; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2001 Feb; 193(4):521-29. PubMed ID: 11181703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and functional interactions between PML and MDM2.
    Wei X; Yu ZK; Ramalingam A; Grossman SR; Yu JH; Bloch DB; Maki CG
    J Biol Chem; 2003 Aug; 278(31):29288-97. PubMed ID: 12759344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.